Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

UPDATE 2-Australia seeks deal with Moderna for domestic production of mRNA vaccines

CoronavirusMay 13, 2021 19:42
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

(Adds quote from prime minister, minister for health,)

By Colin Packham and Renju Jose

CANBERRA, May 13 (Reuters) - Australia is in talks with Moderna Inc MRNA.O to establish domestic manufacturing of messenger ribonucleic acid (mRNA) vaccines such as the company's COVID-19 vaccine, Prime Minister Scott Morrison said on Thursday.

Australia, which on Wednesday agreed to buy 25 million doses of Moderna's COVID-19 vaccine, has pledged to spend A$1.5 billion ($1.2 billion) to revitalise manufacturing across six sectors, including pharmaceuticals.

The move to put manufacturing at the centre of a long-term recovery plan comes amid a realization that Australia has been too reliant on Asia for the supply of essential goods. Sour relations with top trading partner, China, and the pandemic's impact on global supply chains have also strengthened that view.

"Onshore manufacturing would ensure a secure, long-term supply of Moderna's mRNA-based vaccines against COVID-19, including variants, and for potential future pandemics," Morrison said in a statement.

MRNA vaccines prompt the body to make a protein that is part of the virus, triggering an immune response.

Minister for Health Greg Hunt said Moderna was one of several companies Australia was in talks with over domestic production.

"Our hope is that we will have at least one, if not more than one, manufacturing operation in Australia," Hunt told reporters in Canberra.

"I am confident that over the future period, we will have mRNA production in Australia.

STAGNANT INOCULATIONS

Hunt also said the deal with Moderna would aid Australia's inoculation programme.

Citing delays in securing supplies, Australia now expects to finish inoculating its near 26 million population by the end of the year.

But this timetable relies on deliveries of vaccines from Pfizer (NYSE:PFE) PFE.N after Australia in April restricted the use of AstraZeneca (NASDAQ:AZN)'s AZN.L vaccine in people below 50 years due to rare blood-clotting cases.

Australia on Thursday reported seven likely cases of blood clots in people who had recently received AstraZeneca's COVID-19 vaccine.

Australia has administered about 2.5 million doses of the AstraZeneca vaccine, with 18 people believed to have developed the condition.

Moderna will supply Australia with 10 million shots designed to protect against the original strain of the coronavirus this year, and 15 million doses of its updated variant booster shot in 2022. has fared much better than many other developed countries in keeping its COVID-19 numbers relatively low, with just over 29,900 cases and 910 deaths.

($1 = 1.2968 Australian dollars)

UPDATE 2-Australia seeks deal with Moderna for domestic production of mRNA vaccines
 

Related Articles

Sydney emerges from pandemic lockdown, beer in hand
Sydney emerges from pandemic lockdown, beer in hand By Reuters - Oct 11, 2021

By Jonathan Barrett SYDNEY (Reuters) - Sydney's oldest pub opened one hour early on Monday to welcome back its regulars after the city emerged from a more than 100-day lockdown,...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email